Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab.

× No keyword cloud information.

8 in total

1. Positive correlation between etanercept concentration and the decrease in Psoriasis Area and Severity Index scale value.

Authors: Laida Elberdín; Maria Outeda; Pilar Salvador; Sabela Paradela; Rosa María Fernández-Torres; Raquel Iglesias; Eduardo Fonseca; Isabel Martín
Journal: Int J Clin Pharm Date: 2016-07-19

2. Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis.

Authors: José Miguel Senabre Gallego; Jose Rosas; Mariana Marco-Mingot; José Alberto García-Gómez; Gregorio Santos-Soler; Esteban Salas-Heredia; Ana Pons-Bas; Xavier Barber-Vallés; José Antonio Bernal-Vidal; Catalina Cano-Pérez; Mario García-Carrasco; Emilio Flores-Pardo
Journal: Rheumatol Int Date: 2019-03-21 Impact factor: 2.631

Review 3. Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits.

Authors: Manca Ogrič; Matic Terčelj; Sonja Praprotnik; Matija Tomšič; Borut Božič; Snezna Sodin-Semrl; Saša Čučnik
Journal: Immunol Res Date: 2017-02 Impact factor: 2.829

4. Infliximab drug and antibody levels in patients with dermatological conditions.

Authors: L Elberdín; M Outeda; P Salvador; S Paradela; R M Fernández-Torres; R Iglesias; E Fonseca; I Martín
Journal: Int J Clin Pharm Date: 2015-01-23

5. Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease.

Authors: Nerea Martín-Gutiérrez; José Germán Sánchez-Hernández; Noemí Rebollo; Alejandra F Pordomingo; Fernando Muñoz; María José Otero
Journal: Eur J Hosp Pharm Date: 2020-10-28

6. Practical application of acid dissociation in monitoring patients treated with adalimumab.

Authors: Francisca Llinares-Tello; José Rosas-Gómez de Salazar; José Miguel Senabre-Gallego; Gregorio Santos-Soler; Carlos Santos-Ramírez; Esteban Salas-Heredia; Xavier Barber-Vallés; Juan Molina-García
Journal: Rheumatol Int Date: 2014-05-10 Impact factor: 2.631

7. Monitoring drug and antidrug levels: a rational approach in rheumatoid arthritis patients treated with biologic agents who experience inadequate response while being on a stable biologic treatment.

Authors: Diana Mazilu; Daniela Opriş; Cecilia Gainaru; Mihaela Iliuta; Natalia Apetrei; Giorgiana Luca; Andreea Borangiu; Tania Gudu; Alexandra Peltea; Laura Groseanu; Cosmin Constantinescu; Ioana Saulescu; Violeta Bojinca; Andra Balanescu; Denisa Predeteanu; Ruxandra Ionescu
Journal: Biomed Res Int Date: 2014-05-20 Impact factor: 3.411

8. Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels.

Authors: Irene Pérez; Lidia Fernández; Silvia Sánchez-Ramón; Cristina Alba; Ana Zatarain; Mercedes Cañas; Olga N López; David Olivares; Enrique Rey; Carlos Taxonera
Journal: Therap Adv Gastroenterol Date: 2018-06-26 Impact factor: 4.409

8 in total